Education
About Us
Working with TipRanks
Follow Us
Carisma Therapeutics (CARM)
NASDAQ:CARM
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.92M | $ 9.83M | $ 26.54M | $ 11.24M | $ 0.00 |
| Gross Profit | $ -59.21M | $ 3.74M | $ 26.46M | $ 11.24M | $ -219.00K |
| Operating Income | $ -88.73M | $ -56.16M | $ -40.79M | $ -28.38M | $ -36.87M |
| EBITDA | $ -85.89M | $ -51.99M | $ -40.11M | $ -27.93M | $ -107.28M |
| Net Income | $ -86.88M | $ -61.23M | $ -40.77M | $ -28.32M | $ -107.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 77.61M | $ 52.00M | $ 28.55M | $ 51.79M | $ 48.12M |
| Total Assets | $ 89.55M | $ 72.15M | $ 35.45M | $ 58.46M | $ 114.36M |
| Total Debt | $ 3.12M | $ 40.16M | $ 2.63M | $ 3.44M | $ 0.00 |
| Net Debt | $ -74.48M | $ 15.97M | $ -25.92M | $ -48.34M | $ -48.12M |
| Total Liabilities | $ 63.02M | $ 101.28M | $ 9.43M | $ 8.31M | $ 141.06M |
| Stockholders' Equity | $ 26.53M | $ -49.26M | $ 11.63M | $ 35.76M | $ -26.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -82.31M | $ -12.23M | $ -39.20M | $ -27.45M | $ -37.66M |
| Operating Cash Flow | $ -81.18M | $ -7.57M | $ -37.33M | $ -27.01M | $ -37.52M |
| Investing Cash Flow | $ 72.41M | $ -32.56M | $ -1.87M | $ -440.00K | $ -136.00K |
| Financing Cash Flow | $ 62.18M | $ 35.77M | $ 15.96M | $ 72.26M | $ 35.36M |